Peter A. Thompson, Director at Janux Therapeutics, Inc. (JANX), sold 40,400 shares at $20.30 ($820K) on 2021-12-29, disclosed to the SEC on 2021-12-30.
Open-market sale of $820k JANX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.30 | 3,700 | $75K | 9.2% |
| 2 | $20.30 | 36,700 | $745K | 90.8% |
| Total | $20.30 avg | 40,400 | $820K | 100% |
| Filing → |
| SION | SELL | 2026-05-29 | $4K | — | Filing → |
| SION | SELL | 2026-05-11 | $13.4M | — | Filing → |
| SION | SELL | 2026-04-21 | $2.5M | — | Filing → |